Abstract
Lichen amyloidosus is a chronic recalcitrant condition for which there is no effective therapy. Five patients are described with lichen amyloidosus who were treated with the synthetic aromatic retinoid, etretinate. In all patients cutaneous lesions improved but therapy was limited by associated hyperlipidaemia and xeroderma. The histopathological findings and pathogenesis are discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
